SCHEMBL19604229

SCHEMBL19604229

CC(=O)c1ccccc1-c1cnccn1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4C Q9H3R0 1/20 0.57
ALOX5AP P20292 1/20 0.45
FEN1 P39748 1/20 0.45
CYP17A1 P05093 1/20 0.44
HCRTR2 O43614 2/20 0.43
HCRTR1 O43613 1/20 0.43
POLB P06746 1/20 0.42
CYP3A4 P08684 4/20 0.42
GRM5 P41594 1/20 0.41
DAPK3 O43293 1/20 0.40
JAK2 O60674 1/20 0.40
PRKD3 O94806 1/20 0.40
MAP4K4 O95819 1/20 0.40
PAK4 O96013 1/20 0.40
ABL1 P00519 1/20 0.40
CSF1R P07333 1/20 0.40
RET P07949 1/20 0.40
MET P08581 1/20 0.40
PDGFRB P09619 1/20 0.40
PIM1 P11309 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27870881 0.86 HCRTR2 (0.42) KDM4CALOX5APFEN1HCRTR2HCRTR1
SCHEMBL30227102 0.85 KDM4C (0.48) KDM4CHCRTR2HCRTR1CYP3A4KDM4E
SCHEMBL30776208 0.85 KDM4C (0.48) KDM4CHCRTR2HCRTR1CYP3A4KDM4E
SCHEMBL28532968 0.85 KDM4C (0.48) KDM4CHCRTR2HCRTR1CYP3A4KDM4E
SCHEMBL30776205 0.85 KDM4C (0.48) KDM4CHCRTR2HCRTR1CYP3A4KDM4E
SCHEMBL15459585 0.85 SIRT3 (0.43) KDM4CCYP17A1HCRTR2HCRTR1POLB
SCHEMBL19599255 0.84 HCRTR2 (0.44) KDM4CHCRTR2HCRTR1POLBCYP3A4
SCHEMBL45147 0.83 BCAT2 (0.53) KDM4CALOX5APFEN1HCRTR2HCRTR1
SCHEMBL31227852 0.83 BCAT2 (0.53) KDM4CALOX5APFEN1HCRTR2HCRTR1
SCHEMBL30521876 0.83 BCAT2 (0.53) KDM4CALOX5APFEN1HCRTR2HCRTR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170327490-A1 PIPERIDINE ISOXAZOLE AND ISOTHIAZOLE OREXIN RECEPTOR ANTAGONISTS MERCK SHARP & DOHME CORP. (US) 2017-11-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170327490-A1 PIPERIDINE ISOXAZOLE AND ISOTHIAZOLE OREXIN RECEPTOR ANTAGONISTS HCRTR2, HCRTR1, OXTR KDM4C 2077/4885ALOX5AP 1552/4885FEN1 4880/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.